Search Results 1041-1050 of 18349 for Hepatitis b

1. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Serologic status reflecting active hepatitis B or C infection: Participants who are anti-HBc positive and who are hepatitis B surface antigen (HBsAg) ...

2. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... B. Participation eligibility. Participant eligibility includes age, gender ... hepatitis A, B (defined as a known positive hepatitis B surface antigen ...

3. A Study to Learn More About the Relationship between Fetal DNA and the Maternal Immune System - Mayo Clinic

   Participation eligibility · Known immunodeficiency. · Chronic, active viral infections including HIV-1/2, HTLV-1/2, Hepatitis B/C. · Known autoimmune disease.

4. Patient Stories - Elizabeth B. Windgassen, M.D. - Mayo Clinic

   Search for a doctor. Elizabeth B. Windgassen, M.D.. Internist. Request an Appointment · Overview. Patient Stories. Print. PST-20221801.

5. Publications - Patrick B. Bolton, M.D. - Mayo Clinic

   Smith BB, Bosch W, O'Horo JC, Girardo ME, Bolton PB, Murray AW, Hirte IL, Singbartl K, Martin DP. Surgical site infections during the COVID-19 era: A ...

6. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

   Study CC-90002-AML-001 is an open-label, Phase 1 dose escalation (Part A) and expansion (Part B) ... Known chronic hepatitis B or C (HBV/HCV) infection. Ongoing ...

7. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

   ... hepatitis C virus polymerase chain reaction test and participants with hepatitis B with positive hepatitis B surface antigen (HBsAg) antibody are allowed\] * ...

8. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

   Chronic active or acute viral hepatitis A, B, or C infection (testing required for hepatitis B and C), or hepatitis B or C carrier; Use of strong cytochrome ...

9. A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma - Mayo Clinic

   A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma ... hepatitis infection must have ...

10. Exploring Mechanisms of Action and Resistance of Therapeutic Agents in Patients with B-cell Malignancies - Mayo Clinic

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...